Disclosure of interest: Nothing to Disclose Scientific Communications: prognosis & outcomes 03.00 - RECOVERY, REHABILITATION AND OUTCOME - 03.03 - PROGNOSIS AND OUTCOME AFTER STROKE O - ESOC25-76 LONGITUDINAL BRAIN AGEING AFTER STROKE: A MARKER FOR SECONDARY POST-STROKE DEGENERATION AND ITS RELEVANCE FOR MOTOR OUTCOME Raphael Takyi 1 , Jeanette Plantin 2 , Sylvain Charron 1 , Marc Maier 3 , Jean-Claude Baron 4 , Guillaume Turc 5 , Rosso Charlotte 6 , Clment Debacker 1 , Pavel Lindberg 1 1 Institute of Psychiatry and Neuroscience of Paris, Paris, France, 2 Karolinska Institute, Stockholm, Sweden, 3 Universit Paris Cit, INCC UMR 8002, CNRS, Paris, France, 4 Institute of Psychiatry and Neuroscience of Paris, GHU-Paris Psychiatrie et Neurosciences - Neurology, Paris, France, 5 GHU-Paris Psychiatrie et Neuroscience - Neurology, Institute of Psychiatry and Neuroscience of Paris, Paris, France, 6 Sorbonne Universit, Inserm U 1127, APHP Urgences CrebroVasculaires, Hpital Piti- Salptrire, CNRS UMR 7225, STARE team, iCRIN, Inst

It helps the body process and remove environmental toxins and metabolic waste
Al tratarse de un material para investigacin, debe manejarse con las precauciones estndar de laboratorio y sin destino de uso clnico
This is marketing framing, not evidence no clinical trial or peer-reviewed study of any such combination exists in humans
Hereon, we use the terms NAD redox state and NADP redox state to refer to NADH/NAD + ( E NAD ) and NADPH/NADP + ( E NADP ) respectively
[11] - Garcia-Giralt E, Perdereau B, Brixy F, et al